BioPlus Acquisition Corp. (BIOS) to Combine with Avertix Medical in $195M Deal

BioPlus Acquisition Corp. (NASDAQ:BIOS) has entered into a definitive agreement to combine with medical device company Avertix Medical, Inc. at an enterprise value of $195 million, or 2.6x its CY2025E revenue. The Eatontown, New Jersey-based Avertix is a medical technology company commercializing an implantable device for cardiovascular disease management. The combined company is expected to trade
Read More